StonvexLoading…
StonvexStonvexStonvexCore line items from PHUN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.55M | $3.19M | $4.83M | $6.52M |
Operating Income | $-20.52M | $-13.89M | $-45.69M | $-24.03M |
Net Income | $-11.40M | $-10.32M | $-52.78M | $-50.89M |
EPS (Diluted) | $-0.57 | $-0.94 | $-17.62 | $-0.51 |
Total Assets | $120.87M | $114.78M | $6.73M | $54.84M |
Total Liabilities | $24.55M | $7.60M | $18.18M | $29.95M |
Cash & Equivalents | $100.59M | $112.97M | $3.93M | $1.96M |
Free Cash Flow OCF − CapEx | Not available | Not available | $-18.43M | $-27.10M |
Shares Outstanding | 20.19M | 20.16M | 3.85M | 2.06M |